Newer insulin shows promise for better blood sugar control in kids
NCT ID NCT04149262
Summary
This study looked back at real-world data to compare two fast-acting insulins (Fiasp® and NovoRapid®) in children and teenagers with type 1 diabetes. All 44 participants were already using an insulin pump system. The main goal was to see which insulin helped keep blood sugar in a healthy range more often and with fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aristotle University of Thessaloniki
Thessaloniki, 54246, Greece
Conditions
Explore the condition pages connected to this study.